According to Fulgent Genetics 's latest financial reports the company's current revenue (TTM) is $0.28 B. In 2022 the company made a revenue of $0.61 B a decrease over the years 2021 revenue that were of $0.99 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.28 B | -53.27% |
2022 | $0.61 B | -37.64% |
2021 | $0.99 B | 135.37% |
2020 | $0.42 B | 1196.46% |
2019 | $32.52 M | 52.35% |
2018 | $21.35 M | 13.99% |
2017 | $18.73 M | 2.48% |
2016 | $18.27 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $2.45 M | -99.15% | ๐บ๐ธ USA |
Philips PHG | $19.72 B | 6,719.25% | ๐ณ๐ฑ Netherlands |